Putting the call out for more research: The poor evidence base for treating methamphetamine withdrawal

Drug and Alcohol Review

Volumn 30, Issue 2, 2011, Pages 216-222

  Pennay, Amy E ^a,b   Lee, Nicole K ^a,b  

^a TURNING POINT ALCOHOL AND DRUG CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Australia; Methamphetamine; Treatment; Withdrawal

Indexed keywords

METHAMPHETAMINE;

DRUG ABUSE; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL RESEARCH; PSYCHOLOGICAL ASPECT; REVIEW; STANDARD; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

AMPHETAMINE-RELATED DISORDERS; BIOMEDICAL RESEARCH; EVIDENCE-BASED MEDICINE; HUMANS; METHAMPHETAMINE; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME;

EID: 79952306545     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/j.1465-3362.2010.00240.x     Document Type: Review

References (57)

1. United Nations Office on Drugs and Crime. 2007 World Drug Report. Vienna: Vienna International Centre, 2007.
2. Australian Institute of Health and Welfare. 2007 National Drug Strategy Household Survey: detailed findings. Drug statistics series no. 22. Cat. no. PHE 107. Canberra: AIHW, 2008.
3. Shearer J, Sherman J, Wodak A, Van Beek I. Substitution therapy for amphetamine users. Drug Alcohol Rev 2002;21:179-85.
4. Dean A. Pharmacology of psychostimulants. In: Baker A, Lee N, Jenner L, eds. Models of intervention and care for psychostimulant users, 2nd edn. Monograph Series No 51. Canberra: Australian Government Department of Health and Ageing, 2004:35-50.
5. Jenner L, McKetin R. Prevalence and patterns of psychostimulant use. In: Baker A, Lee N, Jenner L, eds. Models of intervention and care for psychostimulant users National Drug Strategy Monograph No 32, 2nd edn. Canberra: Commonwealth of Australia, 2004:13-34.
6. Srisurapanont M, Jarusuraisin N, Kittirattanapaiboon P. Treatment for amphetamine dependence and abuse. Cochrane Database Syst Rev 2001;(4):CD003022.
7. McKetin R, McLaren J, Kelly E, Hall W, Hickman M. Estimating the number of regular and dependent methamphetamine users in Australia. Technical Report No. 230. Sydney: NDARC, UNSW, 2005.
8. Australian Institute of Health and Welfare. Alcohol and other drug treatment services in Australia 2006-07: report on the National Minimum Data Set. Drug treatment series no. 8. Cat. no. HSE 59. Canberra: AIHW, 2008.
9. Baker A, Lee N. A review of psychosocial interventions for amphetamine use. Drug Alcohol Rev 2003;22:323-35.
10. Pennay A, Lee N. Prevention and early intervention of methamphetamine related harm. ADF Prevention Research Quarterly 2008;(6), September.
11. Pennay A, Lee N. Barriers to methamphetamine withdrawal treatment in Australia: findings from a survey of AOD service providers. Drug Alcohol Rev 2009;28:636-40.
12. Shoptaw SJ, Kao U, Heinzerling K, Ling W. Treatment for amphetamine withdrawal. Cochrane Database Syst Rev 2009;(2):CD003021.
13. Jenner L, Saunders JB. Psychostimulant withdrawal and detoxification. In: Baker A, Lee N, Jenner L, eds. Models of intervention and care for psychostimulant users National Drug Strategy Monograph No 32, 2nd edn. Canberra: Commonwealth of Australia, 2004:103-19.
14. McGregor C, Srisurapanont M, Jittiwutikarn J, Laobhripatr S, Wongtan T, White JM. The nature, time course and severity of methamphetamine withdrawal. Addiction 2005;100:1320-9.
15. Cantwell B, McBride AJ. Self detoxification by amphetamine dependent patients: a pilot study. Drug Alcohol Depend 1998;49:157-63.
16. Newton T, Kalechstein A, Duran S, Vansluis N, Ling W. Methamphetamine abstinence syndrome: preliminary findings. Am J Addict 2004;13:248-55.
17. Rawson R. Treatment for stimulant use disorders. TIP Series #33. Rockville: U.S. Department of Health and Human Services, 1999.
18. Gettig JP, Grady SE, Nowosadzka I. Methamphetamine: putting the brakes on speed. J Sch Nurs 2006;22:66-73.
19. Kosten TR, O'Connor PG. Management of drug and alcohol withdrawal. N Engl J Med 2003;348:1786-95.
20. Ritter A, Berends L. Background paper no. 11: Alcohol and drug withdrawal. In: Berends L, Ritter A, eds. Background papers: a review of the Victorian drug treatment service system. Melbourne: Turning Point Alcohol and Drug Centre, 2003:240-65.
21. Gossop M, Johns A, Green L. Opiate withdrawal: inpatient versus outpatient programmes and preferred versus random assignment to treatment. Br Med J 1986;293:103-4.
22. Hayashida M, Alterman AI, McLellan AT, etal. Comparative effectiveness and costs of inpatient and outpatient detoxification of patients with mild-to-moderate alcohol withdrawal syndrome. N Engl J Med 1989;320:358-65.
23. Cole SG, Lehman WE, Cole EA, Jones A. Inpatient vs outpatient treatment of alcohol and drug abusers. Am J Alcohol Abuse 1981;8:329-45.
24. Anglin MD, Burke C, Perrochet B, Stamper E, Dawud-Noursi S. History of the methamphetamine problem. J Psychoactive Drugs 2000;32:137-41.
25. Kenny P, Swan A, Berends L, Jenner L, Hunter B, Mugavin J. Alcohol and other drug withdrawal: practice guidelines. Melbourne: Turning Point Alcohol and Drug Centre, 2009.
26. Klee H, Morris J. Factors that lead young amphetamine misusers to seek help: implications for drug prevention and harm reduction. Drugs Educ Prev Pol 1994;1:289-97.
27. Wright S, Klee H, Reid P. Attitudes of amphetamine users towards treatment services. Drugs Educ Prev Pol 1999;6:71-86.
28. Kamieniecki G, Vincent N, Allsop S, Lintzeris N. Models of intervention and care for psychostimulant users: National Drug Strategy Monograph Series No. 32. Canberra: Commonwealth Department of Health and Family Services, 1998.
29. Roll JM, Petry NM, Stitzer ML, etal. Contingency management for the treatment of methamphetamine use disorders. Am J Psychiatry 2006;163:1993-9.
30. Lee N, Rawson R. A systematic review of cognitive and behavioural therapies for methamphetamine dependence. Drug Alcohol Rev 2008;27:309-17.
31. Knapp WP, Soares B, Farrell M, Silva de Lima M. Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders. Cochrane Database Syst Rev 2009;(2):CD003023.
32. Baker A, Lee NK, Claire M, etal. Brief cognitive behavioural interventions for regular amphetamine users: a step in the right direction. Addiction 2005;100:367-78.
33. Higgins ST. Extending contingency management to the treatment of methamphetamine use disorders. Am J Psychiatry 2006;163:1870-2.
34. Rawson R, Marinelli-Casey P, Douglas Anglin M, etal. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction 2004;99:708-17.
35. Shearer J. Psychosocial approaches to psychostimulant dependence: a systematic review. J Subst Abuse Treat 2007;32:41-52.
36. Jittiwutikan J, Srisurapanont M, Jarusuraisin N. Amineptine in the treatment of amphetamine withdrawal: a placebo-controlled, randomised, double-blind study. J Med Assoc Thai 1997;80:587-92.
37. Srisurapanont M, Jarusuraisin N, Jittiwutikan J. Amphetamine withdrawal: II. A placebo-controlled, randomised, double-blind study of amineptine treatment. Aust NZ J Psychiatry 1999;33:94-8.
38. Kongsakon R, Papadopoulos KI, Saguansiritham R. Mirtazapine in amphetamine detoxification: a placebo-controlled pilot study. Int Clin Psychopharmacol 2005;20:253-6.
39. Cruickshank C, Montebello M, Dyer K, etal. A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal. Drug Alcohol Rev 2008;27:326-33.
40. McGregor C, Srisurapanont M, Mitchell A, Wickes W, White JM. Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: a comparison of mirtazapine and modafinil with treatment as usual. J Subst Abuse Treat 2008;35:334-42.
41. Cox D, Bowers R, McBride A. Reboxetine may be helpful in the treatment of amphetamine withdrawal. Clin Pharmacol 2004;58:100-1.
42. de Dios Molina J, de Pablo S, Lopez-Munoz F, Alamo C, Blasco-Fontecilla H, Gonzalez-Parra S. Monotherapy with reboxetine in amphetamine withdrawal syndrome. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:1353-5.
43. Laqueille X, Dervaux A, El Omari F, Kanit M, Bayle FJ. Methylphenidate effective in treating amphetamine abusers with no other psychiatric disorder. Eur Psychiatry 2005;20:456-7.
44. Tardieu S, Poirier Y, Micallef J, Blin O. Amphetamine-like stimulant cessation in an abusing patient treated with bupropion. Acta Psychiatr Scand 2004;109:75-8.
45. Chan-Ob T, Kuntawongse N, Boonyanaruthee V. Bupropion for amphetamine withdrawal syndrome. J Med Assoc Thai 2001;84:1763-5.
46. Newton TF, Roache JD, De La Garza R, etal. Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving. Neuropsychopharmacology 2006;31:1537.
47. Lee N, Johns L, Jenkinson R, etal. Clinical treatment guidelines for alcohol and drug clinicians. No 14: Methamphetamine dependence and treatment. Fitzroy: Turning Point Alcohol and Drug Centre Inc., 2007.
48. Miller NS, Gold MS. Management of withdrawal syndromes and relapse prevention in drug and alcohol dependence. Am Fam Physician 1998;58:139.
49. Bronson M, Swift R, Peers E. Withdrawal charts: a clinical tool for the management of drug withdrawal symptoms. Aust Nurs J 2005;12:19-21.
50. Srisurapanont M, Jarusuraisin N, Jittiwutikan J. Amphetamine withdrawal: I. Reliability, validity and factor structure of a measure. Aust NZ J Psychiatry 1999;33:89-93.
51. McGregor C, Srisurapanont M, Mitchell A, Longo MC, Cahill S, White JM. Psychometric evaluation of the Amphetamine Cessation Symptom Assessment. J Subst Abuse Treat 2008;34:443-9.
52. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC: American Psychiatric Association, 2000.
53. Kampman KM, Volpicelli JR, McGinnis DE, etal. Reliability and validity of the Cocaine Selective Severity Assessment. Addict Behav 1998;23:449-61.
54. Gawin FH, Kleber H. Abstinence symptomotology and psychiatric diagnosis in cocaine abusers. Arch Gen Psychiatry 1986;43:107-13.
55. Coffey SF, Dansky BS, Carrigan MH, Brady KT. Acute and protracted cocaine abstinence in an outpatient population: a prospective study of mood, sleep and withdrawal symptoms. Drug Alcohol Depend 2000;59:277-86.
56. Satel SL, Price LH, Palumbo JM, etal. Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study. Am J Psychiatry 1991;148:1712-16.
57. Weddington WW, Brown BS, Haertzen CA, etal. Changes in mood, craving and sleep during short-term abstinence reported by male cocaine addicts. Arch Gen Psychiatry 1990;47:861-8.